[WEBINAR] YourEncore Regulatory R.A.N.T: PDUFA and Other Pressing Policy Issues

January 14, 2016
With the upcoming PDUFA renewal, 21st Century Cures uncertainty, and a leadership transition at FDA, it is a dynamic and uncertain time in the biopharma industry. The outcomes of these key policy debates, along with others, will impact how industry pursues drug development and works with patients and regulators to improve public health. To advance the conversation and propose practical ways forward, YourEncore assembled a panel of regulatory experts, including former industry and FDA leaders, to share their best thinking on pressing regulatory policy issues in the biopharma industry.
Previous Article
YourEncore Insights Greatest Hits of 2015

Billboard recently released its “Hot 100 Songs of 2015,” and it inspired me to think about YourE...

Next Article
5 Steps to Protecting Your Competitive Advantage
5 Steps to Protecting Your Competitive Advantage

The single most important value an R&D organization contributes to a company is its know-how – ...